Recall Expanded for Losartan Potassium Tablets – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889
A recall of Torrent Pharmaceuticals Limited’s Losartan Potassium Tablets USP has been expanded to include 8 additional lots. A total of 10 lots are now being recalled at the consumer level, including 2 recalled lots initially announced December 20, 2018.
Torrent’s products are being recalled due to the detection of trace amounts of N-nitrosodiethylamine (NDEA), an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Since July, multiple companies have voluntarily recalled products containing valsartan, irbesartan, and losartan, stemming from concerns about NDEA levels. Earlier this week, Aurobindo Pharma USA announced it was voluntarily recalling 80 lots of valsartan tablets.